Upstream Bio

Today we reported Q4 and full year 2025 financial results and outlined our Phase 3 development strategy for #verekitug. investors.upstreambio.com/news-releases/…

Join our CEO, Rand Sutherland, MD, today March 9th at 1:40 p.m. ET for a fireside chat at the 2026 Leerink Partners Global Healthcare Conference. Tune in live or listen to the replay under the Events tab on the Investors section of our website. investors.upstreambio.com/news-events/ev…

Join our CEO, Rand Sutherland, MD, today March 4th at 9:50 a.m. ET for a fireside chat at the TD Cowen 46th Annual Healthcare Conference. Tune in live or listen to the replay under the Events tab on the Investors section of our website. Learn more here: lnkd.in/ebyUkWJ3

Today at #AAAAI2026, we presented additional analyses from the VIBRANT Phase 2 trial of verekitug in chronic rhinosinusitis with nasal polyps (#CRSwNP). Read more: investors.upstreambio.com/news-releases/…

We’ll be at #AAAAI2026 in Philadelphia presenting additional analyses from the Phase 2 VIBRANT trial of verekitug in patients with #CRSwNP. Learn more: investors.upstreambio.com/news-releases/…

$UPB CEO Rand Sutherland, MD, will participate in fireside chats at two upcoming conferences: @TDCowen Health Care Conference | 3/4, 9:50 AM ET @LeerinkPartners Partners Global Healthcare Conference | 3/9, 1:40 PM ET investors.upstreambio.com/news-releases/…

We’re excited to share top-line results from our Phase 2 VALIANT trial evaluating verekitug, the only known clinical-stage monoclonal antibody targeting the receptor for #TSLP, in adults with severe asthma. Learn more & join today’s webcast at 8am ET: investors.upstreambio.com/news-releases/…

Today, we announced we’ll be hosting a webcast tomorrow morning at 8:00 a.m. ET, reporting top-line results from the Phase 2 VALIANT trial of #verekitug in patients with severe asthma. Learn more: investors.upstreambio.com/news-releases/…

Join our CEO, Rand Sutherland, MD, today at 2:15 p.m. PT for a presentation at the 44th Annual J.P. Morgan Healthcare Conference. A live webcast and replay will be available under the Events tab on the Investors section of our website. Learn more here: investors.upstreambio.com/events/event-d…

Today, we announced that our CEO, Rand Sutherland, MD, will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 2:15 p.m. PT. Learn more here: investors.upstreambio.com/news-releases/…

Proud to support @LS_Cares through our holiday toy drive. Grateful to our team for giving back and helping make the season brighter for families in our community. #LifeScienceCares #GivingBack #LifeSciences

Join our CEO, Rand Sutherland, MD, today at 4:30 p.m. ET for a fireside chat at the @Piper_Sandler 37th Annual Healthcare Conference. Tune in live or listen to the replay on our website. Learn more here: investors.upstreambio.com/news-events/ev…

Today, we announced that our CEO, Rand Sutherland, MD, will be participating in two upcoming investor conferences in December. Learn more here: investors.upstreambio.com/news-releases/…

It’s #WorldCOPDDay. Let’s take a moment to spotlight the continued need for earlier diagnosis and new therapeutic approaches to support those living with #COPD. @GOLD_COPD resources here: goldcopd.org/world-copd-day…

Upstream Bio has been nominated for the Next Cornerstone Healthcare Company of the Year at the 13th Annual NEVY Awards! #NEVYs25 @NewEnglandVC We're honored to be recognized among the New England trailblazers who are driving innovation forward. bit.ly/nevy25

Today at 10:30 a.m. EST, CEO, Rand Sutherland, MD joins the TD Cowen Immunology and Inflammation Summit for a fireside chat. Tune in live or watch the replay later - under Events on our Investors page: investors.upstreambio.com/news-events/ev…

Join us at the @Stifel 2025 Healthcare Conference where our CEO, Rand Sutherland, MD, will be presenting at 9:20 a.m. ET. Tune in live or watch the replay on our website. Learn more here: investors.upstreambio.com/news-events/ev…

Today, we shared financial results for Q3 2025, highlighting recent positive top-line results from the Phase 2 trial of verekitug in #CRSwNP and we remain on track to report top-line results from the Phase 2 trial in severe #asthma in Q1 2026. Learn more: bit.ly/4qAdFhI

Today, we announced that Rand Sutherland, MD, CEO of Upstream Bio, will be participating in three upcoming investor conferences in November. Learn more here: investors.upstreambio.com/news-releases/…

Thank you to the healthcare professionals who support patients with chronic respiratory diseases like #asthma, #CRSwNP & #COPD. At Upstream Bio, we share in the mission to make breathing easier. Learn more: aarc.org/events-and-pro… @AARC_Tweets #RCWeek25